NCT00609908

Brief Summary

Objective: A randomized controlled trial is performed to evaluate the clinical effectiveness of the skin stretching technique for two categories:

  • surface area;
  • Patient and Observer Scar Assessment Scale (POSAS);
  • elasticity;
  • vascularization and pigmentation;
  • thickness;
  • dermal architecture. After 12 months adults will undergo a biopsy of the scar under local anesthesia. The experimental group, treated with the skin stretcher will undergo one extra biopsy of the formerly stretched skin. Intervention: At the start of the operation will be determined by randomization if skin stretching or split skin grafting (acute burn wounds) or serial excision (scar reconstruction category) will be performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2007

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 7, 2008

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

June 26, 2015

Status Verified

June 1, 2015

Enrollment Period

3.5 years

First QC Date

January 25, 2008

Last Update Submit

June 25, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • the surface area of the scar after 12 months

    3 and 12 months after surgery

Secondary Outcomes (1)

  • scar evaluation protocol: - patient and observer scar assessment scale (POSAS); - scar elasticity (Cutometer); - scar vascularization & pigmentation (DermaSpectrometer); - scar thickness

    3 and 12 months after surgery

Study Arms (4)

A1

ACTIVE COMPARATOR

Acute Burn Wounds: Wound debridement and split skin grafting

Procedure: Split skin graft

A2

EXPERIMENTAL

Acute Burn Wounds: excision of the burn wound and primary closure, using a skin stretching device

Procedure: skin stretching device

B1

ACTIVE COMPARATOR

Scar reconstruction: serial excision

Procedure: serial excision

B2

EXPERIMENTAL

Scar reconstruction: primary closure, using skin stretching device

Procedure: skin stretching device

Interventions

After wound bed preparation the skin defect is covered with a skin transplant (split skin graft)

A1

after woundbed preparation the wound is primarily closed by aid of the skin stretching device

A2

as much scar as possible is excised, whereafter the wound is closed

B1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute Burn wounds or scar reconstructions that require surgical treatment;
  • Sufficient healthy skin at (at least) one edge of the wound/scar must be available for the stretching procedure;
  • Age \>= 18 years.

You may not qualify if:

  • Language barrier;
  • Known history of keloid formation;
  • Systemic diseases: Diabetes Mellitus, immunodeficiency, arterial insufficiency;
  • Local or systemic application of corticosteroids;
  • Psychiatric diseases leading to study bias (e.g. automutilation);
  • Skin diseases that lead to collagen and/or elastin abnormalities such as Ehlers Danlos;
  • Radiated skin;
  • Wound located at extremities, exceeding \>33% of circumference (acute burn category).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Red Cross Hospital

Beverwijk, Netherlands

Location

MeSH Terms

Conditions

BurnsCicatrix

Condition Hierarchy (Ancestors)

Wounds and InjuriesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • E Middelkoop, Professor

    VU MC

    PRINCIPAL INVESTIGATOR
  • P.P.M. van Zuijlen, MD, PhD

    Red Cross Hospital Beverwijk

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 25, 2008

First Posted

February 7, 2008

Study Start

December 1, 2007

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

June 26, 2015

Record last verified: 2015-06

Locations